Mega Lifesciences PCL | Cash Flow
Fiscal year is January-December. All values THB Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
624
548
696
795
1,113
1,206
Depreciation, Depletion & Amortization
99
131
145
152
152
148
Other Funds
63
48
35
189
145
120
Funds from Operations
660
727
876
1,135
1,410
1,234
Changes in Working Capital
226
116
266
137
505
329
Net Operating Cash Flow
434
611
610
1,273
905
905
Capital Expenditures
402
219
193
288
228
Sale of Fixed Assets & Businesses
2
2
6
1
4
Purchase/Sale of Investments
-
940
11
295
48
Net Investing Cash Flow
400
1,157
198
735
367
Cash Dividends Paid - Total
846
243
354
407
467
Issuance/Reduction of Debt, Net
231
412
119
44
132
Net Financing Cash Flow
1,138
654
234
451
599
Net Change in Cash
1,187
1,200
175
67
99
Free Cash Flow
55
416
429
1,000
680
Net Assets from Acquisitions
-
-
-
592
-
Change in Capital Stock
2,215
-
-
-
-
Exchange Rate Effect
-
14
3
20
38
About Mega Lifesciences
View Profile
